Cardiol Therapeutics
CRDL · TORONTO
$1.12−$0.03 (−2.61%)TodayMarket closed ·
Prev close $1.15
Who owns CRDL
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 25.2% of CRDL’s shares.
- MMCAP Asset Management13.1%
- Tejara Capital Ltd.4.3%
- Ikarian Capital LLC2.8%
- Elsley (David G)1.1%
- Next 6 largest institutions3.8%
- All other shareholders74.8%
| Holder | Shares | % of shares |
|---|---|---|
| MMCAP Asset Management | 15.60M | 13.12% |
| Tejara Capital Ltd. | 5.11M | 4.30% |
| Ikarian Capital LLC | 3.33M | 2.80% |
| Elsley (David G) | 1.34M | 1.13% |
| Boothbay Fund Management, LLC | 975.72K | 0.82% |
| Citadel Advisors LLC | 796.53K | 0.67% |
| Renaissance Technologies LLC | 772.84K | 0.65% |
| Two Sigma Investments, LP | 746.94K | 0.63% |
| Hamer (Andrew Warwick M.D.) | 739.95K | 0.62% |
| Pekos (Peter) | 506.04K | 0.43% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 60.66K | 0.05% |
| GF Global Cannabis Opportunity Fund | 10.00K | 0.01% |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.07M
- Days to cover
- 3.12
- % of shares outstanding
- 2.58%
- Average daily volume
- 984.59K
- Change since last report
- −7.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.